Affimed N.V.
AFMD · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.6% | -0.6% | -62.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,320% | -9,546.8% | -10,788.4% | -4,677.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,767.1% | -10,033.1% | -12,371% | -4,892.3% |
| EPS Diluted | -0.94 | -1.01 | -1.27 | -1.35 |
| % Growth | 6.9% | 20.5% | 5.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |